RAPP
Rapport Therapeutics, Inc.
31.20$
-3.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -2,006.4% | – | – | – | – | -65.3% | – | -483.4% | |
| – | – | – | – | – | 36.1% | – | – | – | – | 1.1% | – | 4.8% | |
| – | – | – | – | – | 445.6% | – | – | – | – | 34.8% | – | 123.0% | |
| – | – | – | – | – | 186.3% | – | – | – | – | -3.8% | – | 75.1% | |
| – | – | – | – | – | 31.4% | – | – | – | – | 0.4% | – | 2.3% | |
| – | – | – | – | – | 4,434.7% | – | – | – | – | 189.7% | – | -837.8% | |
| – | – | – | – | – | 0.0% | – | – | – | – | 0.0% | – | -0.1% | |
| – | – | – | – | – | 1.0% | – | – | – | – | 2.7% | – | 1,363.9% | |
| – | – | – | – | – | 2,429.3% | – | – | – | – | 127.1% | – | 42.7% | |
| – | – | – | – | – | -2,037.8% | – | – | – | – | -65.7% | – | -485.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.